Provided by Tiger Trade Technology Pte. Ltd.

Amgen

407.27
-14.2400-3.38%
Post-market: 407.970.7000+0.17%19:34 EDT
Volume:2.50M
Turnover:1.03B
Market Cap:219.31B
PE:25.30
High:422.80
Open:421.72
Low:407.13
Close:421.51
52wk High:447.03
52wk Low:283.00
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.86
T/O Rate:0.47%
Dividend:9.80
Dividend Rate:2.41%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:18.76
PE(LYR):28.62

Loading ...

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

TScan Therapeutics Faces Loss of Key Amgen Partnership

TIPRANKS
·
Aug 19

TScan Therapeutics - Amgen to Terminate Research Collaboration and License Agreement with TScan Therapeutics - SEC Filing

THOMSON REUTERS
·
Aug 19

The Bull Case For Amgen (AMGN) Could Change Following Raised 2026 Earnings Guidance And Q2 Beat - Learn Why

Simply Wall St.
·
Aug 19

Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part

Dow Jones
·
Aug 18

Amgen Price Target Raised to $400.00/Share from $350.00 by Cantor Fitzgerald

Dow Jones
·
Aug 18

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 18

Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.

TIPRANKS
·
Aug 15

Amgen Targets Autoimmune Hepatitis With New Inebilizumab Trial

TIPRANKS
·
Aug 15

Amgen Price Target Raised to $380.00/Share from $360.00 by Barclays

Dow Jones
·
Aug 14

Barclays Reaffirms Their Hold Rating on Amgen (AMGN)

TIPRANKS
·
Aug 14

Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 14

U.S. Research Roundup-Cisco, Fox Corp, Target

Reuters
·
Aug 14

Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million

Reuters
·
Aug 14

Barclays Adjusts Price Target on Amgen to $380 From $360, Maintains Equalweight Rating

MT Newswires Live
·
Aug 13

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 12

Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad

THOMSON REUTERS
·
Aug 12

Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11